Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

133.24 -0.76 (-0.57%)
Official Closing Price Updated: 7:00 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
44 45 Next >
A Significant Reversal is in Sight for These 5 Med Tech Companies
Med tech stocks are down YOY despite strong secular tailwinds, cash flow, and dividends; the downturn in action is an opportunity and reversal is at hand. 
Via MarketBeat
How Lawmakers Want To Stop Cronobacter Outbreaks That Spurred Baby Formula Shortage Last Year
Under bipartisan Congressional legislation, baby formula manufacturers must notify the U.S. 
Via Benzinga
5 Good Reasons it's Time to Buy High-Yield Dividend King 3M
3M settled the ear plug lawsuit, clearing the path forward. The stock offers investors a high yield and value that may be too hard to pass up 
Via MarketBeat
Topics Lawsuit
Exposures Financial Legal
1 Stock-Split Stock Billionaires Are Buying Hand Over Fist and 1 Unexpected Stock-Split Stock They're Selling
Some of the world's most successful investors are focusing on stocks. 
Via The Motley Fool
This Is What Whales Are Betting On Abbott Laboratories
Via Benzinga
2 Blue Chip Dividend Stocks That Are Top Buys in August
These two dividend-paying healthcare stocks stand out as top buys right now. 
Via The Motley Fool
How Is The Market Feeling About Abbott Laboratories?
Via Benzinga
U.S. Credit Rating Concerns? Here Are 3 Stocks to Protect Your Portfolio
Looking for stocks to buy amid the U.S. credit rating downgrade? Look no further. These companies have you covered. 
Via InvestorPlace
Want Growing Passive Income? This Dividend King Could Be a Smart Buy
The company boasts one of the longest dividend growth streaks in the healthcare sector. 
Via The Motley Fool
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
Investors can expect steady returns from these two longtime market-beaters. 
Via The Motley Fool
Down 4% to 17%, These Monster Dividend Stocks Could Be Picking Up Steam
These companies have shown they can increase their lucrative dividends regardless of company struggles in recent times. 
Via The Motley Fool
Trillion-Dollar Trio: These 3 Super Growth Stocks Will Dominate the Market by 2035
As companies naturally continue to expand and the stock market grows, trillion-dollar valuations will be a more common occurrence. 
Via InvestorPlace
Is Abbott Laboratories Stock a Buy Now?
The healthcare company recently boosted its guidance. 
Via The Motley Fool
This Is What Whales Are Betting On Abbott Laboratories
Via Benzinga
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years
Via Benzinga
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years
Via Benzinga
2 Best Healthcare Stocks to Buy Right Now
The healthcare sector has plenty of growth tailwinds. 
Via The Motley Fool
Boston Scientific's Farapulse Eyes Stronger US Market Position With Potential FDA Approval
Boston Scientific Corp (NYSE: BSX) will present results from ADVENT pivotal trial for its Farapulse Pulsed Field Ablation (PFA) system at the 2023 European Society of Cardiology Congress on 27 August.... 
Via Benzinga
Exposures Product Safety
Is AbbVie Still a Good Dividend Stock to Buy?
Find out if AbbVie can overcome sinking sales of its top-selling product. 
Via The Motley Fool
2 Top Stocks to Buy in August and Hold Forever
These companies won't disappoint long-term investors. 
Via The Motley Fool
Does Abbott Laboratories' Dividend Make It a Buy?
There's a lot to like about this business when it comes to dividends. 
Via The Motley Fool
Looking Into Abbott Laboratories's Recent Short Interest
Via Benzinga
Glucose Monitor Maker DexCom In Buy Zone After Gapping Higher
Strong Q2 earnings performance propelled DexCom higher. Investors cheered the glucose monitoring leader's bullish sales view and international expansion plans. 
Via MarketBeat
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Dexcom Earnings Tops Estimates, Medical Device Maker Hikes Outlook
Dexcom stock rose after the company reported Q2 earnings and revenue that topped Wall Street targets and raised full-year sales guidance. 
Via Investor's Business Daily
Chronic Pain Specialist Speaks At Panel On Stem Cell-Based Therapies And The Need For Spinal Care Reform – Insights From The Discussion
Chronic back pain is a significant issue in the United States, affecting millions of individuals annually. 
Via Benzinga
Abbott Recalls Amplatzer Steerable Delivery Sheath On Risk Of Air Embolism
Abbott Laboratories (NYSE: ABT) is recalling the Amplatzer Steerable Delivery Sheath due to an increased  
Via Benzinga
2 Top Dividend Stocks to Buy and Hold Forever
They have been paying dividends for a long time. 
Via The Motley Fool
Russia Is Seizing European Company Assets — What US Businesses Are Still At Risk?
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
44 45 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.